ORGANIZATION

• Novartis’ Pullicino to Helm EFPIA Japan from July
  May 22, 2026

• FPMAJ Calls for Greater Support for Stable Drug Supplies in Honebuto Policy
  May 22, 2026

• JPMA Exec Urges Broader Debate on Japan’s CEA System
  May 22, 2026

• COVID-19 Vaccination Rates Fall as Out-of-Pocket Costs Rise: Jiji Survey
  May 21, 2026

• Awareness of HPV Vaccination for Males Stands at 39.4%: Survey
  May 21, 2026

• Pharma Wage Hikes Seen Settling in Low 4% Range Again: UA Zensen Official
  May 21, 2026

• Patient Group Pushes Emergency Steps to Address Concerta Supply Imbalances
  May 18, 2026

• Labor Group Urges Priority Supply of Petrochemical Products for Drug Manufacturing
  May 15, 2026

• JPMA Launches New Legal Entity, Set for October Transition
  May 1, 2026

• Regional Formularies Seen Driving Shift to Quality, Industry Consolidation: Society Head
  April 27, 2026

• JPMA Mulls Proposal to Standardize PMDA Review Reports
  April 27, 2026

• JPWA Urges Caution on Fixed Margins, Citing French Model Shortcomings
  April 24, 2026

• APAC Disbands Drug Discovery WG as Asia Capabilities Rise
  April 23, 2026

• Flight Cuts, Fuel Costs Tied to Iran Crisis Threaten API Imports: Trader
  April 23, 2026

• JPMA to Set Up Task Force on US MFN Policy, First Meeting Seen This Month
  April 21, 2026

• PhRMA Warns Japan Launches Could Erode Global Revenues amid US MFN Policy
  April 20, 2026

• JPMA Exec Frets over Material Cost Surge amid Middle East Crisis
  April 17, 2026

• JPMA Reshaping Organization to Boost Agility as It Shifts to Legal Entity
  April 16, 2026

• JPMA to Launch Nitrosamine Risk Project for APIs in FY2026
  April 15, 2026

• Labor Group Chief Pushes Fundamental Drug Pricing Reform Ahead of Honebuto
  April 8, 2026

ページ

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• Next ›
• 最終 »